Literature DB >> 30521978

Proteomic analysis of olfactory bulb suggests CACNA1E as a promoter of CREB signaling in microbiota-induced depression.

Cheng Huang1, Xun Yang1, Benhua Zeng2, Li Zeng3, Xue Gong4, Chanjuan Zhou5, Jinjun Xia6, Bin Lian6, Yinhua Qin6, Lining Yang1, Lanxiang Liu1, Peng Xie7.   

Abstract

Major depressive disorders impact approximately 17% of the population worldwide, whose high morbidity and considerable adversity have resulted in enormous social and economic burden. In addition, clinically depressed patients often show reduced volume of olfactory bulb (OB) and decreased olfactory sensitivity. Although mounting evidence conveyed that the gut microbiota may implicate the pathophysiology of major depressive disorder (MDD) via the microbe-gut-brain axis, knowledge about its distinctive molecular mechanism is rudimentary. Herein, iTRAQ coupled with LC-MS/MS was applied to compare the OB proteome between "pathological microbiota" and "healthy microbiota" germ-free mice. A set of 367 proteins were differentially identified in the OB, including 119 up-regulated and 248 down-regulated proteins compared with the levels in controls. A combined analysis with significantly changed OB proteins from CUMS depression model supported the role of CREB signaling, whose dysregulation is likely to disrupt the axonogenesis of OB under microbiota condition. With that, the down-regulated CACNA1E and its downstream proteins (CALM/ CaMKII/ CREB/ BDNF) in CREB pathway were validated by Western blot. Meanwhile, the canonical pathways involved Nuclear Receptor Signaling highlighted the fecal microbiota transplantation (FMT) model, which would be a new breakthrough for depressive research. These findings enrich the previous research achievements about the gut microbiota in psychiatric disorders, providing a creative insight into the intricate mechanisms of OB dysfunction in depression. SIGNIFICANCE: Emerging evidence has shown that gut microbiota can greatly influence brain functions and even behaviors. As one of the post-developmental neurogenesis areas for the adult brain, the OB is becoming increasingly important in the study of the pathogenesis of depression. Using an iTRAQ-based proteomics, we identified 367 altered proteins in the OB of fecal microbiota transplanted mouse, which provide a novel insight for further research of the "microbiota-gut-brain axis". In addition, combined analyses with the CUMS depression model and the validation of key proteins by Western blot may assist in the investigation of OB dysfunction in mental sickness.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CACNA1E; Gut microbiota; Major depressive disorder; Olfactory bulb; iTRAQ

Mesh:

Substances:

Year:  2018        PMID: 30521978     DOI: 10.1016/j.jprot.2018.11.023

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  10 in total

1.  Linking Diabetes Mellitus with Alzheimer's Disease: Bioinformatics Analysis for the Potential Pathways and Characteristic Genes.

Authors:  Cheng Huang; Juyu Luo; Xueyi Wen; Keshen Li
Journal:  Biochem Genet       Date:  2021-11-15       Impact factor: 1.890

2.  Alterations of Lysine Acetylation Profile in Murine Skeletal Muscles Upon Exercise.

Authors:  Dehuan Liang; Cheng Chen; Song Huang; Sujuan Liu; Li Fu; Yanmei Niu
Journal:  Front Aging Neurosci       Date:  2022-05-03       Impact factor: 5.702

3.  Hippocampus-specific regulation of long non-coding RNA and mRNA expression in germ-free mice.

Authors:  Chanjuan Zhou; Xuechen Rao; Haiyang Wang; Benhua Zeng; Yue Yu; Jianjun Chen; Jiaju Zhong; Xunzhong Qi; Li Zeng; Peng Zheng; Wei Hong; Peng Xie
Journal:  Funct Integr Genomics       Date:  2019-11-01       Impact factor: 3.410

4.  Antidepressant-like effects of the Guanxin Danshen formula via mediation of the CaMK II-CREB-BDNF signalling pathway in chronic unpredictable mild stress-induced depressive rats.

Authors:  Weijie Xie; Xiangbao Meng; Yadong Zhai; Tianyuan Ye; Ping Zhou; Fengwei Nan; Guibo Sun; Xiaobo Sun
Journal:  Ann Transl Med       Date:  2019-10

5.  Commensal Microbiota Regulation of Metabolic Networks During Olfactory Dysfunction in Mice.

Authors:  Haiyang Wang; Lanxiang Liu; Xuechen Rao; Tingjia Chai; Benhua Zeng; Xiaotong Zhang; Ying Yu; Chanjuan Zhou; Juncai Pu; Wei Zhou; Wenxia Li; Hanping Zhang; Hong Wei; Peng Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-19       Impact factor: 2.570

6.  Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression.

Authors:  Yiyun Liu; Haiyang Wang; Siwen Gui; Benhua Zeng; Juncai Pu; Peng Zheng; Li Zeng; Yuanyuan Luo; You Wu; Chanjuan Zhou; Jinlin Song; Ping Ji; Hong Wei; Peng Xie
Journal:  Transl Psychiatry       Date:  2021-11-08       Impact factor: 6.222

Review 7.  Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?

Authors:  Zarina Mamieva; Elena Poluektova; Valery Svistushkin; Vasily Sobolev; Oleg Shifrin; Francisco Guarner; Vladimir Ivashkin
Journal:  World J Gastroenterol       Date:  2022-03-28       Impact factor: 5.742

8.  Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review.

Authors:  Arthi Chinna Meyyappan; Evan Forth; Caroline J K Wallace; Roumen Milev
Journal:  BMC Psychiatry       Date:  2020-06-15       Impact factor: 3.630

9.  iTRAQ-Based Quantitative Proteomics Analysis of HeLa Cells Infected With Chlamydia muridarum TC0668 Mutant and Wild-Type Strains.

Authors:  Yingzi Wang; Emmanuel Wirekoh Arthur; Na Liu; Xiaofang Li; Wenjing Xiang; Asamoah Maxwell; Zhongyu Li; Zhou Zhou
Journal:  Front Microbiol       Date:  2019-11-07       Impact factor: 5.640

10.  Integrated phosphoproteomic and metabolomic profiling reveals perturbed pathways in the hippocampus of gut microbiota dysbiosis mice.

Authors:  Haiyang Wang; Lanxiang Liu; Xuechen Rao; Benhua Zeng; Ying Yu; Chanjuan Zhou; Li Zeng; Peng Zheng; Juncai Pu; Shaohua Xu; Ke Cheng; Hanping Zhang; Ping Ji; Hong Wei; Peng Xie
Journal:  Transl Psychiatry       Date:  2020-10-13       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.